Chaperoning of the a1-adenosine receptor by endogenous adenosine-an extension of the retaliatory metabolite concept

Molecular Pharmacology

Volumn 87, Issue 1, 2015, Pages 39-51

  Kusek, Justyna ^a   Yang, Qiong ^a   Witek, Martin ^a   Gruber, Christian W ^a   Nanoff, Christian ^a   Freissmuth, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; CHAPERONE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; MUTANT PROTEIN; OXYGEN; VASOPRESSIN RECEPTOR; ENZYME INHIBITOR;

ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; FEEDBACK SYSTEM; GLYCOSYLATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HYPOXIA; METABOLITE; MOLECULAR BIOLOGY; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; WILD TYPE; DRUG EFFECTS; GENETICS; METABOLISM; MUTATION; PHYSIOLOGICAL STRESS; PLASMA CELL;

ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONISTS; ENDOPLASMIC RETICULUM; ENZYME INHIBITORS; HEK293 CELLS; HUMANS; MOLECULAR CHAPERONES; MUTATION; PLASMA CELLS; PROTEIN FOLDING; RECEPTOR, ADENOSINE A1; STRESS, PHYSIOLOGICAL;

EID: 84919772176     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.094045     Document Type: Article

References (41)

1. Aarons RD, Nies AS, Gal J, Hegstrand LR, and Molinoff PB (1980) Elevation of b-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest 65:949-957.
2. Alderman EL, Coltart DJ, Wettach GE, and Harrison DC (1974) Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med 81:625-627.
3. Arslan G, Kull B, and Fredholm BB (2002) Anoxia redistributes adenosine A(2A) receptors in PC12 cells and increases receptor-mediated formation of cAMP. Naunyn Schmiedebergs Arch Pharmacol 365:150-157.
4. Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, and Young JD (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280:15880-15887.
5. Bergmayr C, Thurner P, Keuerleber S, Kudlacek O, Nanoff C, Freissmuth M, and Gruber CW (2013) Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor. J Biol Chem 288:28831-28844.
6. Davies LP, Jamieson DD, Baird-Lambert JA, and Kazlauskas R (1984) Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: pharmacological activities and potent inhibition of adenosine kinase. Biochem Pharmacol 33: 347-355.
7. Decking UKM, Schlieper G, Kroll K, and Schrader J (1997) Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res 81: 154-164.
8. Eshaq RS, Stahl LD, Stone R, 2nd, Smith SS, Robinson LC, and Leidenheimer NJ (2010) GABA acts as a ligand chaperone in the early secretory pathway to promote cell surface expression of GABAA receptors. Brain Res 1346:1-13.
9. Filardo EJ and Thomas P (2012) Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 153:2953-2962.
10. Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14:1315-1323.
11. Gloeckner CJ, Boldt K, Schumacher A, Roepman R, and Ueffing M (2007) A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7:4228-4234.
12. Grossfield A, Pitman MC, Feller SE, Soubias O, and Gawrisch K (2008) Internal hydration increases during activation of the G-protein-coupled receptor rhodopsin. J Mol Biol 381:478-486.
13. Hammond LC, Bonnet C, Kemp PJ, Yates MS, and Bowmer CJ (2004) Chronic hypoxia up-regulates expression of adenosine A1 receptors in DDT1-MF2 cells. Biochem Pharmacol 67:421-426.
14. Hanyaloglu AC and von Zastrow M (2008) Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537-568.
15. Hohenegger M, Mitterauer T, Voss T, Nanoff C, and Freissmuth M (1996) Thiophosphorylation of the G protein β subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G α subunits. Mol Pharmacol 49:73-80.
16. Ingolia DE, Yeung CY, Orengo IF, Harrison ML, Frayne EG, Rudolph FB, and Kellems RE (1985) Purification and characterization of adenosine deaminase from a genetically enriched mouse cell line. J Biol Chem 260:13261-13267.
17. Jastrzebska B, Palczewski K, and Golczak M (2011) Role of bulk water in hydrolysis of the rhodopsin chromophore. J Biol Chem 286:18930-18937.
18. Keuerleber S, Thurner P, Gruber CW, Zezula J, and Freissmuth M (2012) Reengineering the collision coupling and diffusion mode of the A2A -adenosine receptor: palmitoylation in helix 8 relieves confinement. J Biol Chem 287:42104-42118.
19. Kobayashi S, Zimmermann H, and Millhorn DE (2000) Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport. J Neurochem 74:621-632.
20. Leidenheimer NJ and Ryder KG (2014) Pharmacological chaperoning: a primer on mechanism and pharmacology. Pharmacol Res 83:10-19.
21. Leioatts N, Mertz B, Martínez-Mayorga K, Romo TD, Pitman MC, Feller SE, Grossfield A, and Brown MF (2014) Retinal ligand mobility explains internal hydration and reconciles active rhodopsin structures. Biochemistry 53:376-385.
22. Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Katritch V, Han GW, Roth CB, Heitman LH, and IJzerman AP et al. (2012) Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337:232-236.
23. Málaga-Diéguez L, Yang Q, Bauer J, Pankevych H, Freissmuth M, and Nanoff C (2010) Pharmacochaperoning of the A1 adenosine receptor is contingent on the endoplasmic reticulum. Mol Pharmacol 77:940-952.
24. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, and Lefkowitz RJ (1994) Enhanced myocardial function in transgenic mice overexpressing the b 2-adrenergic receptor. Science 264:582-586.
25. Miller RR, Olson HG, Amsterdam EA, and Mason DT (1975) Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med 293:416-418.
26. Milojevic T, Reiterer V, Stefan E, Korkhov VM, Dorostkar MM, Ducza E, Ogris E, Boehm S, Freissmuth M, and Nanoff C (2006) The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol 69:1083-1094.
27. Morello JP, Petäjä-Repo UE, Bichet DG, and Bouvier M (2000) Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci 21:466-469.
28. Nanoff C and Freissmuth M (2012) ER-bound steps in the biosynthesis of G proteincoupled receptors. Subcell Biochem 63:1-21.
29. Newby AC (1984) Adenosine and the concept of retaliatory metabolites. Trends Biochem Sci 9:42-44.
30. Olsson RA and Pearson JD (1990) Cardiovascular purinoceptors. Physiol Rev 70: 761-845.
31. Pankevych H, Korkhov V, Freissmuth M, and Nanoff C (2003) Truncation of the A1 adenosine receptor reveals distinct roles of the membrane-proximal carboxyl terminus in receptor folding and G protein coupling. J Biol Chem 278:30283-30293.
32. Park E and Rapoport TA (2012) Mechanisms of Sec61/SecY-mediated protein translocation across membranes. Annu Rev Biophys 41:21-40.
33. Petäjä-Repo UE, Hogue M, Laperriere A, Bhalla S, Walker P, and Bouvier M (2001) Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 276:4416-4423.
34. Petäjä-Repo UE, Hogue M, Laperriere A, Walker P, and Bouvier M (2000) Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J Biol Chem 275: 13727-13736.
35. Romo TD, Grossfield A, and Pitman MC (2010) Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics. Biophys J 98:76-84.
36. Sallette J, Pons S, Devillers-Thiery A, Soudant M, Prado de Carvalho L, Changeux JP, and Corringer PJ (2005) Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46:595-607.
37. St Hilaire C, Carroll SH, Chen H, and Ravid K (2009) Mechanisms of induction of adenosine receptor genes and its functional significance. J Cell Physiol 218: 35-44.
38. Tonack S, Tang C, and Offermanns S (2013) Endogenous metabolites as ligands for G protein-coupled receptors modulating risk factors for metabolic and cardiovascular disease. Am J Physiol Heart Circ Physiol 304:H501-H513.
39. Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, and Van Tol HH (2005) Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. J Biol Chem 280:19350-19357.
40. Ward JL, Sherali A, Mo ZP, and Tse CM (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275:8375-8381.
41. Wüller S, Wiesner B, Löffler A, Furkert J, Krause G, Hermosilla R, Schaefer M, Schülein R, Rosenthal W, and Oksche A (2004) Pharmacochaperones posttranslationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors. J Biol Chem 279:47254-47263.